4//SEC Filing
Townsend Adam J. 4
Accession 0001127602-25-001845
CIK 0001492422other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 3:39 PM ET
Size
4.6 KB
Accession
0001127602-25-001845
Insider Transaction Report
Form 4
Townsend Adam J.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-01-22$30.43/sh−3,323$101,104→ 84,745 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 21, 2025.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001773588
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 3:39 PM ET
- Size
- 4.6 KB